Atorvastatin for protease inhibitor-related hyperlipidaemia

被引：38

作者：

Murillas, J ^{[1
]}

Martín, T ^{[1
]}

Ramos, A ^{[1
]}

Portero, JL ^{[1
]}

机构：

[1] Hosp Clin Puerta Hierro, Madrid, Spain

来源：

AIDS | 1999年 / 13卷 / 11期

关键词：

D O I：

10.1097/00002030-199907300-00030

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1424 / 1425

页数：2

共 5 条

[1] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[2] Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].

Carr, A ;

Samaras, K ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1998, 351 (9119) :1881-1883

[3] Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy [J].

Gervasoni, C ;

Ridolfo, AL ;

Trifirò, G ;

Santambrogio, S ;

Norbiato, G ;

Musicco, M ;

Clerici, M ;

Galli, M ;

Moroni, M .

AIDS, 1999, 13 (04) :465-471

[4] Severe premature coronary artery disease with protease inhibitors [J].

Henry, K ;

Melroe, H ;

Huebsch, J ;

Hermundson, J ;

Levine, C ;

Swensen, L ;

Daley, J .

LANCET, 1998, 351 (9112) :1328-1328

[5] Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities [J].

Henry, K ;

Melroe, H ;

Huebesch, J ;

Hermundson, J ;

Simpson, J .

LANCET, 1998, 352 (9133) :1031-1032

← 1 →